JP2024527623A5 - - Google Patents

Info

Publication number
JP2024527623A5
JP2024527623A5 JP2024502652A JP2024502652A JP2024527623A5 JP 2024527623 A5 JP2024527623 A5 JP 2024527623A5 JP 2024502652 A JP2024502652 A JP 2024502652A JP 2024502652 A JP2024502652 A JP 2024502652A JP 2024527623 A5 JP2024527623 A5 JP 2024527623A5
Authority
JP
Japan
Prior art keywords
pyrazine
carboxamide
pyridine
methylimidazo
methylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024502652A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527623A (ja
JP7851393B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/070137 external-priority patent/WO2023001794A1/en
Publication of JP2024527623A publication Critical patent/JP2024527623A/ja
Publication of JP2024527623A5 publication Critical patent/JP2024527623A5/ja
Application granted granted Critical
Publication of JP7851393B2 publication Critical patent/JP7851393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024502652A 2021-07-20 2022-07-19 癌の治療のためのｈｐｋ１阻害剤としての置換ピラジン－２－カルボキサミド阻害剤 Active JP7851393B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163223633P 2021-07-20 2021-07-20
US63/223,633 2021-07-20
PCT/EP2022/070137 WO2023001794A1 (en) 2021-07-20 2022-07-19 Substituted pyrazine-2-carboxamides as hpk1 inhibitors for the treatment of cancer

Publications (3)

Publication Number Publication Date
JP2024527623A JP2024527623A (ja) 2024-07-25
JP2024527623A5 true JP2024527623A5 (https=) 2025-07-29
JP7851393B2 JP7851393B2 (ja) 2026-04-24

Family

ID=82932501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502652A Active JP7851393B2 (ja) 2021-07-20 2022-07-19 癌の治療のためのｈｐｋ１阻害剤としての置換ピラジン－２－カルボキサミド阻害剤

Country Status (9)

Country Link
US (1) US20240374606A1 (https=)
EP (1) EP4373817B1 (https=)
JP (1) JP7851393B2 (https=)
CN (1) CN117693503A (https=)
AR (1) AR126500A1 (https=)
ES (1) ES3036245T3 (https=)
TW (1) TW202321239A (https=)
UY (1) UY39865A (https=)
WO (1) WO2023001794A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117402161A (zh) 2022-07-06 2024-01-16 上海科恩泰生物医药科技有限公司 一种具有fgfr抑制作用的亚砜亚胺类化合物、包含其的药物组合物及其用途
US20260092074A1 (en) * 2022-09-23 2026-04-02 Guangzhou Vinnocent Pharmaceutical Limited Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof
WO2024240242A1 (zh) * 2023-05-25 2024-11-28 正大天晴药业集团股份有限公司 含有酰胺取代的芳香环的化合物、其药物组合物及用途

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076980A1 (en) 1999-06-10 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
PL377215A1 (pl) * 2002-10-17 2006-01-23 Amgen Inc. Pochodne benzimidazolu oraz ich zastosowanie w charakterze ligandów receptora waniloidowego
MA42456B1 (fr) 2015-06-25 2021-06-30 Univ Health Network Inhibiteurs de hpk1 et leurs procédés d'utilisation
US20180072741A1 (en) 2016-09-09 2018-03-15 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US10280164B2 (en) 2016-09-09 2019-05-07 Incyte Corporation Pyrazolopyridone compounds and uses thereof
CN115819417A (zh) 2016-09-09 2023-03-21 因赛特公司 作为hpk1调节剂的吡唑并吡啶衍生物及其用于治疗癌症的用途
WO2018049214A1 (en) 2016-09-09 2018-03-15 Incyte Corporation Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
US10793467B2 (en) 2016-10-07 2020-10-06 Nihon Yamamura Glass Co., Ltd. Crystallized glass sealing material
WO2018081531A2 (en) 2016-10-28 2018-05-03 Ariad Pharmaceuticals, Inc. Methods for human t-cell activation
WO2018102366A1 (en) 2016-11-30 2018-06-07 Ariad Pharmaceuticals, Inc. Anilinopyrimidines as haematopoietic progenitor kinase 1 (hpk1) inhibitors
WO2018152220A1 (en) 2017-02-15 2018-08-23 Incyte Corporation Pyrazolopyridine compounds and uses thereof
CN110402248B (zh) 2017-03-15 2023-01-06 豪夫迈·罗氏有限公司 作为hpk1抑制剂的氮杂吲哚类
EP3601259B1 (en) 2017-03-30 2022-02-23 F. Hoffmann-La Roche AG Isoquinolines as inhibitors of hpk1
EP3638669A1 (en) 2017-06-13 2020-04-22 Bayer Pharma Aktiengesellschaft Substituted pyrrolopyridine-derivatives
EP3638670B1 (en) 2017-06-13 2021-07-21 Bayer Pharma Aktiengesellschaft Substituted pyrrolopyridine-derivatives as map4k1 modulators for the treatment of cancer diseases
WO2018228925A1 (en) 2017-06-13 2018-12-20 Bayer Pharma Aktiengesellschaft Substituted pyrrolopyridine-derivatives
CA3070013A1 (en) 2017-07-18 2019-01-24 Bayer Pharma Aktiengesellschaft Substituted pyrrolopyridine-derivatives
CN111163780A (zh) 2017-07-18 2020-05-15 诺维逊生物股份有限公司 作为腺苷拮抗剂的杂环化合物
EP3679414A4 (en) 2017-09-08 2021-05-05 Commscope Technologies LLC HEAT DISSIPATING ENCLOSURE
EP3707138B1 (en) 2017-11-06 2022-07-13 Bristol-Myers Squibb Company Isofuranone compounds useful as hpk1 inhibitors
EP3755703B1 (en) 2018-02-20 2022-05-04 Incyte Corporation N-(phenyl)-2-(phenyl)pyrimidine-4-carboxamide derivatives and related compounds as hpk1 inhibitors for treating cancer
US10752635B2 (en) 2018-02-20 2020-08-25 Incyte Corporation Indazole compounds and uses thereof
US10745388B2 (en) 2018-02-20 2020-08-18 Incyte Corporation Indazole compounds and uses thereof
US11299473B2 (en) 2018-04-13 2022-04-12 Incyte Corporation Benzimidazole and indole compounds and uses thereof
WO2019206049A1 (en) 2018-04-25 2019-10-31 Zhuhai Yufan Biotechnologies Co., Ltd Hpk1 inhibitors, preparation method and application thereof
CN112243439A (zh) 2018-06-13 2021-01-19 百济神州有限公司 作为hpk1抑制剂的吡咯并[2,3-b]吡啶或吡咯并[2,3-b]吡嗪及其用途
TW202019905A (zh) 2018-07-24 2020-06-01 瑞士商赫孚孟拉羅股份公司 異喹啉化合物及其用途
TW202012405A (zh) 2018-07-24 2020-04-01 瑞士商赫孚孟拉羅股份公司 萘啶化合物及其用途
CN113015526A (zh) 2018-09-19 2021-06-22 豪夫迈·罗氏有限公司 螺环2,3-二氢-7-氮杂吲哚化合物及其用途
EP3856724A1 (en) 2018-09-30 2021-08-04 F. Hoffmann-La Roche AG Cinnoline compounds and for the treatment of hpk1-dependent disorders such as cancer
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
WO2020072695A1 (en) 2018-10-03 2020-04-09 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof
WO2020070332A1 (en) 2018-10-05 2020-04-09 Ichnos Sciences S.A. Oxindole compounds for use as map4k1 inhibitors
US11203591B2 (en) 2018-10-31 2021-12-21 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
US11142525B2 (en) 2018-11-15 2021-10-12 Pfizer Inc. Azalactam compounds as HPK1 inhibitors
WO2020103896A1 (en) 2018-11-22 2020-05-28 Beigene, Ltd. Pyrrolo[2,3-b]pyridines as hpk1 inhibitor and uses thereof
WO2020120257A1 (en) 2018-12-11 2020-06-18 Bayer Aktiengesellschaft Substituted pyrrolopyridine-derivatives
US12486264B2 (en) 2019-03-26 2025-12-02 Janssen Pharmaceutica Nv Bicyclic HPK1 inhibitors
US12492194B2 (en) 2019-03-26 2025-12-09 Janssen Pharmaceutica Nv HPK1 inhibitors
JP7503851B2 (ja) 2019-05-06 2024-06-21 アイカーン スクール オブ メディスン アット マウント シナイ Ｈｐｋ１の分解剤としてのヘテロ二官能性化合物
EP3972695A1 (en) 2019-05-23 2022-03-30 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
MA56462A (fr) 2019-07-04 2022-05-11 Qilu Regor Therapeutics Inc Inhibiteurs de hpk1 et leurs utilisations
TWI848141B (zh) 2019-07-04 2024-07-11 英屬開曼群島商百濟神州有限公司 及其用途
US12459958B2 (en) 2019-07-17 2025-11-04 Beone Medicines I Gmbh Tricyclic compounds as HPK1 inhibitor and the use thereof
BR112022002059A2 (pt) 2019-08-06 2022-06-07 Incyte Corp Formas sólidas de um inibidor de hpk1
WO2021032148A1 (en) 2019-08-21 2021-02-25 Beigene, Ltd. Aminopyrazine compounds as hpk1 inhibitor and the use thereof
MX2022002877A (es) 2019-09-13 2022-08-08 Nimbus Saturn Inc Antagonistas de cinasa progenitora hematopoyetica 1 (hpk1) y sus usos.
AU2021284676A1 (en) 2020-06-01 2023-02-02 Wigen Biomedicine Technology (shanghai) Co., Ltd. New pyrazine compound

Similar Documents

Publication Publication Date Title
US11759455B2 (en) Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
EP2603500B1 (en) Inhibitors of bruton's tyrosine kinase
US8901313B2 (en) 6,5-heterocyclic propargylic alcohol compounds and uses therefor
JP2024527623A5 (https=)
AU2015357585B2 (en) 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
EP3209664B1 (en) Bicyclic heteroaryl amine compounds as pi3k inhibitors
RS61759B1 (sr) Jedinjenja 1-cijano-pirolidina kao inhibitori usp30
US20150259340A1 (en) Novel kinase inhibitors
JP2023554596A (ja) 化合物、組成物及び方法
JP7681116B2 (ja) カルボニル置換ジアザスピロ化合物及びその使用
US20250304577A1 (en) Tyk2 inhibitors
JP2025523848A (ja) チロシンキナーゼ２阻害剤及びその使用
EP4274832A1 (en) Tyk2 inhibitors
JP2022165429A (ja) ヒスタミンｈ４受容体調節作用を有する新規トリアジン誘導体
WO2026022742A1 (en) Cbl-b inhibitor and uses thereof
WO2025194074A1 (en) Kinase modulators and methods of use thereof
WO2025096697A1 (en) Ripk1 inhibitors and methods of use
AU2024373566A1 (en) Ripk1 inhibitors and methods of use
TW202602445A (zh) 作為ｋｒａｓ調節劑的螺環化合物及其用途
AU2023336561A1 (en) Heterocyclic derivatives as janus kinase inhibitors
HK40087489A (en) Aryl or heteroaryl derivative
EP4137481A1 (en) Aryl or heteroaryl derivative